rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BDSX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Biodesix director Jack Schuler buys $1 million in company stock
      Nov 12Investing.comBDSX
      Biodesix Stock Crashes Nearly 30% After Q3 Revenue Miss, Slashes 2026 Outlook
      Nov 6BenzingaBDSX
      Biodesix Inc (BDSX) (Q3 2026) Earnings Call Highlights: Revenue Growth Offset by Sales Force ...
      Nov 6Yahoo FinanceBDSX
      What Biodesix (BDSX) Said on Its Q3 Earnings Call
      Nov 5Yahoo FinanceBDSX
      Biodesix Q3 2026 Earnings Call Transcript
      Nov 5BenzingaBDSX
      Biodesix, Inc. (BDSX) Reports Q3 Loss, Lags Revenue Estimates
      Nov 5Yahoo FinanceBDSX
      Earnings To Watch: Biodesix Inc (BDSX) Q3 2026 -- GF Value Sees 14% Upside
      Nov 4Yahoo FinanceBDSX
      All You Need to Know About Biodesix (BDSX) Rating Upgrade to Buy
      Oct 29Yahoo FinanceBDSX
      Will Biodesix, Inc. (BDSX) Report Negative Earnings Next Week? What You Should Know
      Oct 29Yahoo FinanceBDSX
      H.C. Wainwright reiterates Biodesix stock rating on lung nodule framework
      Oct 22Investing.comBDSX
      Biodesix adds digital diagnostics to lung testing platform
      Oct 19Investing.comBDSX
      Biodesix (BDSX) Stock Sees Fair Value Lift As Analysts Back MRD Growth
      Oct 15Yahoo FinanceBDSX
      Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests

      BDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.

      Sep 28Yahoo FinanceBDSX
      Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher

      Biodesix, Inc. (NASDAQ:BDSX) reported progress in two collaborative Molecular Residual Disease (MRD) monitoring programs designed to detect circulating tumor DNA (ctDNA) in blood following cancer treatment.

      Sep 24Yahoo FinanceBDSXBIOTMO
      Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher
      Sep 24Investing.comBDSXBIOTMO
      Biodesix (BDSX) Stock Gets Fair Value Boost On Revenue And Margin Optimism

      Biodesix has seen its fair value estimate move from US$30.83 to US$34.00, which works out to roughly a 10% uplift in the price target range used by analysts. Recent research coverage links this shift to a mix of optimism around revenue momentum and margin potential, along with some caution about execution and the timing of profitability. As you read on, you will see how these moving parts shape the current analyst narrative and what to watch as it evolves from here. Stay updated as the Fair...

      Sep 18Yahoo FinanceBDSX
      Biodesix: Growing Fast While Trading Below Many Diagnostics Peers (NASDAQ:BDSX)
      Sep 10Seeking AlphaBDSX
      What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?

      Does Biodesix, Inc. (BDSX) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Aug 31Yahoo FinanceBDSX
      Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?

      The consensus price target hints at a 26.7% upside potential for Biodesix (BDSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

      Aug 31Yahoo FinanceBDSX

      This is the newest page. Registered accounts read further back.